0.00Open0.00Pre Close0 Volume0 Open Interest14.76Strike Price0.00Turnover254.25%IV-103.31%PremiumMay 16, 2025Expiry Date7.50Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8399Delta0.0610Gamma0.94Leverage Ratio-0.0266Theta-0.0050Rho-0.79Eff Leverage0.0039Vega
Immersion Stock Discussion
Immersion Stuns With 4,900% Revenue Surge to $475M in Q3 Earnings Blowout
buy it at the lowest price for now because (1) IMMR gets suport at MA5, MA10, MA20 and MA50 of week line level which is symbol of long term rise; (2) IMMR reported several very explosive quarterly reports, indicating steady growth.
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Monday, 16th December at 8:50 am
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results
IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (NASDAQ: NVNO) ("enVVeno" or the "Company"), a compan...
oversold undervalued
No comment yet